The global human papilloma virus testing market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing number of HPV-related diseases and rising awareness about HPV infection among people. The increasing prevalence of HPV-related diseases such as cervical cancer, anal cancer, and head and neck cancers is also driving the growth of this market.
The global human papilloma virus testing market by type is segmented into Pap smear test and HPV DNA test. The Pap smear test segment accounted for a share of over 90% in 2018 owing to its widespread use in diagnostic centers, hospitals, clinics for detecting cervical cancer or other types of cancers caused by human papillomavirus (HPV). On the other hand, the HPV DNA test segment accounted for less than 10% share in 2018 due to its high cost associated with it which restricts its use only in specialized laboratories or research institutes.
The global human papilloma virus testing market by application is segmented into diagnostic centers, hospitals, clinics. In 2018, diagnostic centers accounted for over 50% share owing to their wide availability across various regions globally which makes them more accessible than hospitals or clinics that are available only in specific regions such as North America or Europe respectively. Hospitals accounted for less than 10% share while clinics accounted for less than 5%.
- The human papilloma virus (HPV) is the most common sexually transmitted infection in the United States.
- HPV is a group of more than 150 related viruses that can infect humans and animals, including birds and reptiles.
- HPV is spread from one person to another through intimate contact with an infected person's skin or mucous membranes, usually during vaginal, anal or oral sex.
- There are more than 40 types of HPV that can infect humans; some types cause warts on the hands or feet while others cause genital warts or cancerous changes in cells lining the cervix, vulva, vagina and anus.
- The Centers for Disease Control and Prevention (CDC) estimates that about 79 million Americans are currently infected with HPV.
Industry Growth Insights published a new data on “Human Papilloma Virus Testing Market”. The research report is titled “Human Papilloma Virus Testing Market research by Types (Pap Smear Test, HPV DNA Test), By Applications (Diagnostic Centers, Hospitals, Clinic), By Players/Companies Roche, Agilent Technologies, Inc. , Becton, Dickinson and Company , Qiagen N.V. , Thermo Fisher Scientific Inc. , Abbott Laboratories , Hologic Inc. , Cepheid Inc. , Seegene Inc. , Takara Bio Inc. , DaAn Gene Co., Ltd. of Sun Yat-Sen University , Promega Corporation , Greiner Bio-One International GmbH (Greiner Holding AG) , Enzo Biochem Inc. , Norgen Biotek Corp. , DiagCor Bioscience Inc Ltd , Hybribio Limited , Zytovision GmbH , Arbor Vita Corporation , Medical & Biological Laboratories Co., Ltd , Fujirebio Diagnostics, Inc.”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Human Papilloma Virus Testing Market Research Report
By Type
Pap Smear Test, HPV DNA Test
By Application
Diagnostic Centers, Hospitals, Clinic
By Companies
Roche, Agilent Technologies, Inc. , Becton, Dickinson and Company , Qiagen N.V. , Thermo Fisher Scientific Inc. , Abbott Laboratories , Hologic Inc. , Cepheid Inc. , Seegene Inc. , Takara Bio Inc. , DaAn Gene Co., Ltd. of Sun Yat-Sen University , Promega Corporation , Greiner Bio-One International GmbH (Greiner Holding AG) , Enzo Biochem Inc. , Norgen Biotek Corp. , DiagCor Bioscience Inc Ltd , Hybribio Limited , Zytovision GmbH , Arbor Vita Corporation , Medical & Biological Laboratories Co., Ltd , Fujirebio Diagnostics, Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Human Papilloma Virus Testing Market Report Segments:
The global Human Papilloma Virus Testing market is segmented on the basis of:
Types
Pap Smear Test, HPV DNA Test
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostic Centers, Hospitals, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Agilent Technologies, Inc.Â
- Becton, Dickinson and CompanyÂ
- Qiagen N.V.Â
- Thermo Fisher Scientific Inc.Â
- Abbott LaboratoriesÂ
- Hologic Inc.Â
- Cepheid Inc.Â
- Seegene Inc.Â
- Takara Bio Inc.Â
- DaAn Gene Co., Ltd. of Sun Yat-Sen UniversityÂ
- Promega CorporationÂ
- Greiner Bio-One International GmbH (Greiner Holding AG)Â
- Enzo Biochem Inc.Â
- Norgen Biotek Corp.Â
- DiagCor Bioscience Inc LtdÂ
- Hybribio LimitedÂ
- Zytovision GmbHÂ
- Arbor Vita CorporationÂ
- Medical & Biological Laboratories Co., LtdÂ
- Fujirebio Diagnostics, Inc.
Highlights of The Human Papilloma Virus Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pap Smear Test
- HPV DNA Test
- By Application:
- Diagnostic Centers
- Hospitals
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Human Papilloma Virus Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Human papilloma virus (HPV) testing is a way to determine if you have the HPV virus. The test can help identify whether you have an HPV infection and may need treatment.
Some of the key players operating in the human papilloma virus testing market are Roche, Agilent Technologies, Inc.‚Â , Becton, Dickinson and Company‚Â , Qiagen N.V.‚Â , Thermo Fisher Scientific Inc.‚Â , Abbott Laboratories‚Â , Hologic Inc.‚Â , Cepheid Inc.‚Â , Seegene Inc.‚Â , Takara Bio Inc.‚Â , DaAn Gene Co., Ltd. of Sun Yat-Sen University‚Â , Promega Corporation‚Â , Greiner Bio-One International GmbH (Greiner Holding AG)‚Â , Enzo Biochem Inc.‚Â , Norgen Biotek Corp.‚Â , DiagCor Bioscience Inc Ltd‚Â , Hybribio Limited‚Â , Zytovision GmbH‚Â , Arbor Vita Corporation‚Â , Medical & Biological Laboratories Co., Ltd‚Â , Fujirebio Diagnostics, Inc..
The human papilloma virus testing market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Human Papilloma Virus Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Human Papilloma Virus Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Human Papilloma Virus Testing Market - Supply Chain
4.5. Global Human Papilloma Virus Testing Market Forecast
4.5.1. Human Papilloma Virus Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Human Papilloma Virus Testing Market Size (000 Units) and Y-o-Y Growth
4.5.3. Human Papilloma Virus Testing Market Absolute $ Opportunity
5. Global Human Papilloma Virus Testing Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Human Papilloma Virus Testing Market Size and Volume Forecast by Type
5.3.1. Pap Smear Test
5.3.2. HPV DNA Test
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Human Papilloma Virus Testing Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Human Papilloma Virus Testing Market Size and Volume Forecast by Application
6.3.1. Diagnostic Centers
6.3.2. Hospitals
6.3.3. Clinic
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Human Papilloma Virus Testing Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Human Papilloma Virus Testing Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Human Papilloma Virus Testing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Human Papilloma Virus Testing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Human Papilloma Virus Testing Demand Share Forecast, 2019-2026
9. North America Human Papilloma Virus Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Human Papilloma Virus Testing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Human Papilloma Virus Testing Market Size and Volume Forecast by Application
9.4.1. Diagnostic Centers
9.4.2. Hospitals
9.4.3. Clinic
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Human Papilloma Virus Testing Market Size and Volume Forecast by Type
9.7.1. Pap Smear Test
9.7.2. HPV DNA Test
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Human Papilloma Virus Testing Demand Share Forecast, 2019-2026
10. Latin America Human Papilloma Virus Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Human Papilloma Virus Testing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Human Papilloma Virus Testing Market Size and Volume Forecast by Application
10.4.1. Diagnostic Centers
10.4.2. Hospitals
10.4.3. Clinic
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Human Papilloma Virus Testing Market Size and Volume Forecast by Type
10.7.1. Pap Smear Test
10.7.2. HPV DNA Test
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Human Papilloma Virus Testing Demand Share Forecast, 2019-2026
11. Europe Human Papilloma Virus Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Human Papilloma Virus Testing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Human Papilloma Virus Testing Market Size and Volume Forecast by Application
11.4.1. Diagnostic Centers
11.4.2. Hospitals
11.4.3. Clinic
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Human Papilloma Virus Testing Market Size and Volume Forecast by Type
11.7.1. Pap Smear Test
11.7.2. HPV DNA Test
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
1.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Human Papilloma Virus Testing Demand Share, 2019-2026
12. Asia Pacific Human Papilloma Virus Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Human Papilloma Virus Testing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Human Papilloma Virus Testing Market Size and Volume Forecast by Application
12.4.1. Diagnostic Centers
12.4.2. Hospitals
12.4.3. Clinic
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Human Papilloma Virus Testing Market Size and Volume Forecast by Type
12.7.1. Pap Smear Test
12.7.2. HPV DNA Test
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Human Papilloma Virus Testing Demand Share, 2019-2026
13. Middle East & Africa Human Papilloma Virus Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Human Papilloma Virus Testing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Human Papilloma Virus Testing Market Size and Volume Forecast by Application
13.4.1. Diagnostic Centers
13.4.2. Hospitals
13.4.3. Clinic
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Human Papilloma Virus Testing Market Size and Volume Forecast by Type
13.7.1. Pap Smear Test
13.7.2. HPV DNA Test
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Human Papilloma Virus Testing Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Human Papilloma Virus Testing Market: Market Share Analysis
14.2. Human Papilloma Virus Testing Distributors and Customers
14.3. Human Papilloma Virus Testing Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Agilent Technologies, Inc.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Becton, Dickinson and Company
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Qiagen N.V.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Thermo Fisher Scientific Inc.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Abbott Laboratories
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Hologic Inc.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Cepheid Inc.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Seegene Inc.
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Takara Bio Inc.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. DaAn Gene Co., Ltd. of Sun Yat-Sen University
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Promega Corporation
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Greiner Bio-One International GmbH (Greiner Holding AG)
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Enzo Biochem Inc.
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Norgen Biotek Corp.
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. DiagCor Bioscience Inc Ltd
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Hybribio Limited
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Zytovision GmbH
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Arbor Vita Corporation
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Medical & Biological Laboratories Co., Ltd
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
